News

Reed's Secures $10 Million in Public Offering and NYSE Listing

Reed's Secures $10 Million in Public Offering and NYSE Listing

Reed's, Inc. Successfully Closes $10 Million Offering

Reed's, Inc. (NYSE: REED), a frontrunner in the natural beverage sector, recently announced a notable achievement in its growth strategy with the closure of its public offering. They have successfully raised $10 million through the sale of 2.5 million shares of common stock, accompanied by 2.5 million warrants. Each share is priced at $4.00, and the warrants have an attractive exercise price of $4.50, with a five-year expiration period.

Details of the Public Offering

In a strong display of market confidence, Reed's broadened its financial base by offering the compound Securities, providing an excellent investment opportunity bolstered by a 45-day option allowing underwriters to acquire additional 375,000 shares. This transaction reaffirms the company’s robust financial health and aims to boost shareholder value.

Uplisting to NYSE American: A Strategic Shift

Adding to the excitement, Reed's made an impactful transition to the NYSE American on December 5, 2025. Moving to a larger and more prestigious stock exchange is not just a shift in venue; it symbolizes Reed's commitment to achieving higher visibility among investors. With this transition, the company has ended its trading on the OTC Markets, signaling a new era of growth and opportunity.

CEO's Perspective on Growth

Cyril Wallace, the CEO of Reed's, expressed enthusiasm about this pivotal phase for the company. Wallace stated, "This is another milestone for Reed's that reflects our investment in growth with a long-term path toward profitability and the value we are committed to deliver for shareholders." His words resonate as a reminder of the impact this listing will have on liquidity and the company's future trajectory.

How the Offering Supports Strategic Goals

The proceeds from this public offering not only bolster Reed's financial stability but also catalyze the company’s ambitions for expansion and innovation in the beverage sector. The funds are earmarked for enhancing product development, marketing initiatives, and broadening distribution channels—all essential components of Reed's ongoing efforts to elevate its brand in the competitive market.

A Brief Overview of Reed's, Inc.

Founded in 1989, Reed's, Inc. has carved its niche with a distinct portfolio of artisan ginger beverages. Building a reputation over four decades, Reed's has captured the attention of consumers with its commitment to high-quality, better-for-you beverage options. The brand names Reed's®, Virgil's®, and Flying Cauldron® have become familiar heralds of craft brewing excellence, with products now available in over 32,000 stores across the nation.

Future Vision and Market Potential

As the company steps into this new chapter on the NYSE American, it sets the stage for enhanced potential. The leadership remains focused on driving value for investors by leveraging a broader capital base and establishing a deeper connection with consumers seeking healthier beverage alternatives. With an eye on strategic partnerships and customer engagement, Reed's is poised for sustainable growth.

Contact Information for Investors

Investors looking to engage with Reed's can reach out to the Investor Relations team. For inquiries, contact Sean Mansouri, CFA, or Aaron D'Souza at Elevate IR via email at ir@reedsinc.com or call (720) 330-2829. They are available to discuss the company’s exciting trajectory and address any investor concerns.

Frequently Asked Questions

What was the amount raised in Reed's recent public offering?

Reed's raised approximately $10 million through its public offering, offering investors shares at $4.00 each.

When did Reed's begin trading on the NYSE American?

Reed's officially began trading on the NYSE American on December 5, 2025, marking a significant milestone for the company.

What is the exercise price of the warrants associated with the offering?

The exercise price of the warrants issued in the offering is $4.50 per share, which can be exercised immediately for five years.

Who acted as the underwriter for the public offering?

A.G.P./Alliance Global Partners served as the sole book-running manager for the offering, with Roberts & Ryan, Inc. acting as a co-manager.

What brands does Reed's, Inc. encompass?

Reed's, Inc. operates under its well-known brands, including Reed's®, Virgil's®, and Flying Cauldron®, all of which focus on premium, natural beverages.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of the Network API Market by 2030

Updated Category News Views 125

Network API Market Overview As technology evolves, the demand for Network APIs is accelerating, and projections show the market will grow from USD 1.96 billion to an impressive USD 6.13 billion by 2030, reflecting a compound annual growth rate (CAGR) of 25.7% during the forecast period. This surge signifies a shift in how businesses leverage APIs to enhance connectivity...

Continue Reading
Quebec City Real Estate Market Sees Strong Activity Surge

Updated Category News Views 179

Quebec City Real Estate Market Activity in August As summer comes to a close, the residential real estate market in Quebec City is experiencing notable activity, achieving the second highest sales levels in 25 years for this month. This trend highlights the remarkable resilience and ongoing demand in a market that continues to change. Sales Data Overview In August, the...

Continue Reading
Understanding Market Trends: Income Strategies with IQQQ ETF

Updated Category News Views 151

Navigating the Current Tech Market Dynamics This year, the Nasdaq Composite index has outperformed other major indices, showing a solid increase of more than 21%. This surge in technology stocks has, however, been volatile, with the index recently experiencing a dip of roughly 2%. Concerns around a potential bubble in artificial intelligence have contributed to this...

Continue Reading
Boussard & Gavaudan Holding Limited: Latest NAV Update

Updated Category News Views 272

Boussard & Gavaudan Holding Limited Overview Boussard & Gavaudan Holding Limited is a well-known closed-ended investment company recognized within the finance industry for its effective management strategies. This article provides recent updates on the company's net asset value (NAV) and market activities. Estimated NAV Information The Directors of Boussard & Gavaudan...

Continue Reading
Currency Insights: Dollar and Yen Dynamics Amid Changes

Updated Category News Views 153

Current Trends in Currency Markets The US dollar is maintaining its strength as holiday trading continues with low volumes, while US Treasury yields are gradually rising. Although the dollar remains resilient against various currencies, it has shown some weakness against the Japanese yen and Canadian dollar lately. Markets are keenly observing the impact of potential...

Continue Reading